for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EMA approves new manufacturing site in France for Moderna's COVID-19 vaccine

June 11 (Reuters) - The European Medicines Agency (EMA) on Friday approved a new manufacturing site for the production of Moderna Inc’s COVID-19 vaccine finished product.

The site is operated by Recipharm and located in Monts, France, EMA’s committee for human medicines said. (Reporting by Vishwadha Chander in Bengaluru; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up